.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually f...
.Aelis Farma's chances of getting a fast, beneficial decision on a $100 thousand option remittance h...
.ProKidney has actually ceased some of a pair of period 3 trials for its own cell therapy for renal ...
.Vaxcyte revealed what professionals named "spectacular" phase 1/2 information for its own 31-valent...
.Recursion has actually stumbled via a very early exam of its own tech-enabled strategy to medicatio...
.Call it a scenario of really good chemical make up: Acepodia, a biotech based on Nobel Champion sci...
.Praxis Precision Medicines has actually racked up yet another midphase gain in epilepsy this year, ...
.After running away a professional grip numerous years back, Dyne Therapeutics has actually shown br...
.Arrowhead Pharmaceuticals has actually presented its give in advance of a prospective face-off alon...
.Pfizer and Valneva might possess about two additional years to hang around before they help make th...